scholarly journals Neurological variability in chemotherapy‑induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review

2017 ◽  
Author(s):  
Chen Makranz ◽  
Salome Khutsurauli ◽  
Yosef Kalish ◽  
Ruth Eliahou ◽  
Luna Kadouri ◽  
...  
Keyword(s):  
Literature Review ◽  
Posterior Reversible Encephalopathy Syndrome ◽  
Thrombotic Microangiopathy ◽  
Case Reports ◽  
Posterior Reversible Encephalopathy ◽  
Reversible Encephalopathy

scholarly journals Postpartum Posterior Reversible Encephalopathy Syndrome (PRES): Three Case Reports and Literature Review

2019 ◽  
Vol 2019 ◽  
pp. 1-11 ◽  
Author(s):  
Eleonora Marcoccia ◽  
Maria Grazia Piccioni ◽  
Michele Carlo Schiavi ◽  
Vanessa Colagiovanni ◽  
Ilaria Zannini ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Literature Review ◽  
Young Women ◽  
Posterior Reversible Encephalopathy Syndrome ◽  
Case Reports ◽  
Rare Complication ◽  
Neurological Sequelae ◽  
Posterior Reversible Encephalopathy ◽  
Acute Changes ◽  
Reversible Encephalopathy

Posterior reversible encephalopathy syndrome is a rare complication generally associated with headache and acute changes in blood pressure. Delay in the diagnosis and treatment may result in death or in irreversible neurological sequelae. We present three cases of PRES occurring in young women during puerperium. We report a literature review ranged from January 1990 to June 2015 describing clinical features, diagnostic and medical approach, and maternal outcome.

scholarly journals Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report

2020 ◽  
Vol 13 (2) ◽  
pp. 1013-1019 ◽  
Author(s):  
Anannya Patwari ◽  
Vineel Bhatlapenumarthi ◽  
Sheila K. Pascual
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Posterior Reversible Encephalopathy Syndrome ◽  
Kinase Inhibitor ◽  
Case Reports ◽  
Cell Cancer ◽  
Mri Findings ◽  
Posterior Reversible Encephalopathy ◽  
First Case ◽  
Reversible Encephalopathy

We report here a rare case of atypical posterior reversible encephalopathy syndrome (PRES) due to oral tyrosine kinase inhibitor cabozantinib. No case reports of such have been found in our literature search. The patient, a 70-year-old female with metastatic renal cell cancer on oral tyrosine kinase inhibitor cabozantinib, was brought into the emergency room because of confusion and seizures, found to have elevated blood pressure and atypical MRI findings consistent with PRES due to cabozantinib.

Sign in / Sign up

Export Citation Format

Share Document